Dr. Hua Chen's lab focuses on understanding how selective serotonin reuptake inhibitors (SSRIs), commonly prescribed antidepressants, affect growth during puberty. By analyzing large databases of health records, the lab aims to reveal how SSRIs impact height growth in adolescents, particularly boys, and whether stopping the medication can normalize growth rates later. This research is vital for informing clinical decisions regarding the use of SSRIs in young patients.

Dr. Mingfu Wu's lab at the University of Houston focuses on understanding how cells in the heart communicate during its development. They are particularly interested in a newly identified structure called signaling bridges, which may influence how heart cells behave and develop. By studying these interactions, the lab hopes to uncover new insights into heart diseases, particularly left ventricular noncompaction cardiomyopathy, a condition that can be fatal.

Dr. Ming Hu's lab at the University of Houston focuses on understanding how buprenorphine, a medication for opioid use disorder, affects dental health. They study why high levels of buprenorphine appear in oral fluids and how this contributes to dental caries. The goal is to find ways to reduce the drug's concentration in the mouth without affecting its overall effectiveness, improving the treatment experience for patients.

Dr. Ashok Kumar’s lab at the University of Houston focuses on understanding skeletal muscle wasting, particularly in the context of cancer and aging. They investigate signaling pathways that contribute to muscle loss and how these pathways can be targeted for potential therapies. Another area of research includes studying Rhabdomyosarcoma, a childhood cancer, where they explore how certain proteins promote tumor growth and differentiation. The ultimate goal is to find effective treatments for muscle-related conditions and cancers that affect muscle tissue.

Dr. Guizhen Zhao's lab focuses on understanding the complex interplay between metabolism and epigenetics in the context of atherosclerosis, a leading cause of cardiovascular diseases. The lab investigates how certain proteins, specifically the BAF60c protein, influence vascular cell function and disease progression. By learning how to manipulate these molecules, the lab aims to develop novel therapeutic strategies to combat cardiovascular diseases.

Dr. Gregory Cuny's lab at the University of Houston focuses on creating new treatments for cryptosporidiosis, a disease caused by parasitic protozoa that affects people, especially children and those with weakened immune systems. The lab is working on selective inhibitors that target a specific protein involved in the survival of these parasites. This research aims to improve treatment options for those infected, as current medications are limited and ineffective for certain populations.

Dr. Vincent H Tam's lab focuses on fighting multidrug-resistant bacteria that no longer respond to standard antibiotics. The lab is developing a precision medicine platform that can select effective combinations of antibiotics tailored to individual patients. This research is crucial as it aims to prevent a return to the pre-antibiotic era by finding new ways to use existing drugs more effectively.